Linked Data API

Show Search Form

Search Results

179004
registered interest false more like this
date less than 2015-02-10more like thismore than 2015-02-10
answering body
Department of Health more like this
answering dept id 17 more like this
answering dept short name Health more like this
answering dept sort name Health more like this
hansard heading Hereditary Diseases remove filter
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health, with reference to Part 5 (a) (ii) of the Mitochndrial Donation Regulations 2015, how the Human Fertilisation and Embryology Authority plans to define a "significant risk" of having or developing serious mitochondrial disease. more like this
tabling member constituency Stoke-on-Trent South more like this
tabling member printed
Robert Flello remove filter
uin 224080 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2015-02-23more like thismore than 2015-02-23
answer text <p>The Human Fertilisation and Embryology Authority has advised that if Parliament passes the Human Fertilisation and Embryology (Mitochondrial Donation) Regulations 2015, it will need to design a regulatory process of which the consideration of “significant risk” is a part. In designing that process it will take into account, where relevant, the existing regulatory process for embryo testing (preimplantation genetic diagnosis).</p><p> </p> more like this
answering member constituency Battersea more like this
answering member printed Jane Ellison more like this
question first answered
less than 2015-02-23T16:05:17.44Zmore like thismore than 2015-02-23T16:05:17.44Z
answering member
3918
label Biography information for Jane Ellison more like this
tabling member
1569
label Biography information for Robert Flello more like this